Popular Articles

BioElectronics Prepares For General Surgical Recovery FDA 510(k) Premarketing Application Submission
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced the Company is currently preparing an application for 510(k) premarket notification for submission to the Food and Drug Administration (FDA) for general surgical recovery. The filing will request an indication for the adjunct of use in palliative treatment of postoperative edema and pain in superficial soft tissue.

AMT Receives EMEA Orphan Drug Designation For Acute Intermittent Porphyria
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced that the European Medicines Agency has granted Orphan Drug Designation to AMT"s gene therapy product AMT-021 for the treatment of acute intermittent porphyria (AIP).
News of the day
Gene Test Determines Transplant Drug Tolerance
A simple genetic test can determine a kidney transplant patient"s tolerance for a potent anti-rejection medication, according to an upcoming study in the Journal of the American Society Nephrology (JASN). The test could allow doctors to individualize each patient"s dose, optimizing the drug"s benefits and minimizing its side effects.
Endocrinology

TB-HIV Link Emphasised In Uganda Event

"I am stopping TB and controlling HIV" was the theme of an event marking World TB Day (24 March) in Uganda"s Masindi district. The Union Uganda Office participated in this event, which attracted representatives from both government and a wide variety of NGOs, as well as the public. World TB Day is a joint TB-HIV event in Masindi District, Uganda "I am stopping TB and controlling HIV" was the theme chosen by Uganda to commemorate World TB Day on Tuesday, 24 March 2009. The function was held at Boma grounds in the district of Masindi and was attended by a wide variety of organisations and government and district representatives working in TB and TB/HIV, as well as the general public. District leaders not only attended in large numbers, but they also made moving speeches that demonstrated their understanding of TB -- a credit to the mobilisation and sensitisation activities carried out by the district health team. During his speech, the National TB Programme manager noted that this was the first time he had seen the district political as well as technical leaders fully participate in the commemoration of the World TB Day. Thanks were given to the TB CAP (TB Control Assistance Program) for its financial support of the event. TB CAP is USAID"s centrally funded project supporting the implementation of the international Stop TB strategy, which is coordinated by The Union in Uganda. The Honorable Kabakumba Masiko, Minister for Information and National Guidance, was the event"s chief guest. She spoke with passion about the individual"s role in TB control and challenged those present to go and have free screening for TB if they have cough for two weeks or more. She also promised to champion the Stop TB campaign in cabinet and parliament. The chief guest then launched the new TB logo -- special signage to help patients easily identify TB diagnostic and treatment units -- and referral directories designed to help health workers identify the nearest health facilities where patients can receive TB and HIV services. She visited stalls, including that of The Union Uganda Office (TBCAP), and was happy to note that the documents displayed had been disseminated down to the implementers. WHO


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):